Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
65.00
-0.95 (-1.44%)
At close: Oct 1, 2026
NSE:AAKAAR Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 162.43 | 55.51 | 3 | 1.89 | 22.67 |
Cash & Short-Term Investments | 162.43 | 55.51 | 3 | 1.89 | 22.67 |
Cash Growth | 192.63% | 1752.12% | 58.40% | -91.65% | -19.59% |
Accounts Receivable | 372.25 | 280.05 | 162.63 | 102.33 | 35.69 |
Other Receivables | - | - | - | - | 0.03 |
Receivables | 372.59 | 281.44 | 162.63 | 102.33 | 51.68 |
Inventory | 197.5 | 145.54 | 141.79 | 112.53 | 69.98 |
Prepaid Expenses | 2.48 | 3.04 | 1.56 | 1.26 | - |
Other Current Assets | 31.12 | 32.83 | 19.1 | 4.2 | 8.79 |
Total Current Assets | 766.12 | 518.36 | 328.08 | 222.22 | 153.12 |
Property, Plant & Equipment | 1.69 | 2.28 | 2.71 | 3.55 | 2.02 |
Long-Term Investments | 1.56 | 1.99 | 2.32 | 2.16 | 1.62 |
Other Intangible Assets | 5.18 | 0.09 | 0.07 | 0.07 | - |
Long-Term Deferred Tax Assets | 4.7 | 3.96 | 3.54 | 2.61 | 0.13 |
Other Long-Term Assets | 11.79 | 12.12 | 3.37 | 1.68 | 1.06 |
Total Assets | 794.17 | 541.6 | 340.09 | 232.29 | 157.96 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 18.85 | 35.12 | 18.17 | 25.3 | 14.5 |
Accrued Expenses | 25.65 | 24.84 | 22.77 | 17.95 | 8.21 |
Short-Term Debt | 185.34 | 227.38 | 150.57 | 58.74 | - |
Current Income Taxes Payable | 2.62 | - | - | 0.16 | 8.65 |
Other Current Liabilities | 6.37 | 12.23 | 14.87 | 26.9 | 2.03 |
Total Current Liabilities | 238.83 | 299.56 | 206.37 | 129.06 | 33.39 |
Long-Term Debt | - | - | - | - | 38.19 |
Pension & Post-Retirement Benefits | 9.83 | 9.45 | 8.3 | 6.62 | - |
Other Long-Term Liabilities | 0 | - | -0 | - | -0 |
Total Liabilities | 248.66 | 309.02 | 214.67 | 135.68 | 71.58 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 141.73 | 104.22 | 7 | 7 | 7 |
Additional Paid-In Capital | 247.94 | 38.9 | - | - | - |
Retained Earnings | 155.84 | 89.46 | 118.26 | 89.55 | 79.37 |
Comprehensive Income & Other | - | - | 0.16 | 0.05 | - |
Shareholders' Equity | 545.51 | 232.58 | 125.42 | 96.61 | 86.37 |
Total Liabilities & Equity | 794.17 | 541.6 | 340.09 | 232.29 | 157.96 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 185.34 | 227.38 | 150.57 | 58.74 | 38.19 |
Net Cash (Debt) | -22.91 | -171.88 | -147.57 | -56.85 | -15.53 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -1.72 | -17.44 | -16.14 | -6.23 | -1.71 |
Filing Date Shares Outstanding | 14.17 | 10.42 | 9.1 | 9.1 | 9.1 |
Total Common Shares Outstanding | 14.17 | 10.42 | 9.1 | 9.1 | 9.1 |
Working Capital | 527.29 | 218.79 | 121.71 | 93.16 | 119.73 |
Book Value Per Share | 38.49 | 22.32 | 13.78 | 10.62 | 9.49 |
Tangible Book Value | 540.33 | 232.49 | 125.35 | 96.54 | 86.37 |
Tangible Book Value Per Share | 38.12 | 22.31 | 13.77 | 10.61 | 9.49 |
Machinery | 5.89 | 5.91 | 5.12 | 4.63 | 4.25 |